ABSCF OTC
AB Science S.A.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -22.8%
1Y: -11.1%
3Y: -84.5%
5Y: -91.2%
$1.12
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1M
+10.5% ▲
5Y CAGR: -7.4%
Gross Profit
$1M
+112.6% ▲
5Y CAGR: -2.1%
Operating Income
-$6M
+54.7% ▲
Net Income
-$8M
+34.7% ▲
EPS (Diluted)
$-0.15
+37.5% ▲
EBITDA
-$5M
+61.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $2M | $2M | $958K | $970K | $1M |
| YoY Growth | +0.8% | +1.5% | -40.4% | +1.3% | +10.5% |
| Cost of Revenue | $69K | $111K | $31K | $383K | -$176K |
| Gross Profit | $2M | $1M | $927K | $587K | $1M |
| Gross Margin | 95.6% | 93.1% | 96.8% | 60.5% | 116.4% |
| R&D Expenses | $13M | $11M | $13M | $14M | $4M |
| SG&A Expenses | $3M | $4M | $2M | $4M | $2M |
| Operating Expenses | $16M | $15M | $17M | $14M | $7M |
| Operating Income | -$15M | -$14M | -$16M | -$13M | -$6M |
| Operating Margin | -931.7% | -859.2% | -1663.6% | -1384.4% | -567.4% |
| Interest Expense | $117K | $1M | $2M | $4M | $2M |
| Income Before Tax | -$15M | -$14M | -$14M | -$12M | -$8M |
| Tax Expense | $8K | $36K | $4K | $0 | $0 |
| Net Income | -$15M | -$14M | -$14M | -$12M | -$8M |
| Net Margin | -950.4% | -900.0% | -1421.2% | -1235.6% | -730.5% |
| EPS (Diluted) | $-0.34 | $-0.30 | $-0.29 | $-0.24 | $-0.15 |
| EBITDA | -$14M | -$13M | -$16M | -$13M | -$5M |
| Shares Outstanding | 44M | 48M | 47M | 50M | 52M |